(E)-3-[[[3-[2-(7-CHLORO-2-QUINOLINYL)ETHENYL]PHENYL]-[[(3-DIMETHYLAMINO)-3-OXOPROPYL]THIO]METHYL]THIO]-PROPANOIC ACID, SODIUM SALT
-
(E)-3-[[[3-[2-(7-CHLORO-2-QUINOLINYL)ETHENYL]PHENYL]-[[(3-DIMETHYLAMINO)-3-OXOPROPYL]THIO]METHYL]THIO]-PROPANOIC ACID, SODIUM SALT
structure -
-
CAS No:
115104-28-4
-
Formula:
C26H27ClN2O3S2
-
Chemical Name:
(E)-3-[[[3-[2-(7-CHLORO-2-QUINOLINYL)ETHENYL]PHENYL]-[[(3-DIMETHYLAMINO)-3-OXOPROPYL]THIO]METHYL]THIO]-PROPANOIC ACID, SODIUM SALT
-
Synonyms:
CS-2183;(E)-3-[[[3-[2-(7-CHLORO-2-QUINOLINYL)ETHENYL]PHENYL]-[[(3-DIMETHYLAMINO)-3-OXOPROPYL]THIO]METHYL]THIO]-PROPANOIC ACID, SODIUM SALT;L 660711, SODIUM SALT;3-[[[3-[(E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl][[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]propanoic acid;3-[[[3-[(E)-2-(7-Chloroquinolin-2-yl)ethenyl]phenyl][[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]propanoic acid;MK-571;MK-571 NA;MK-571 SODIUM SALT
-
CAS No:
Description
Yellow Solid
MK 571 is a member of quinolines.
MK-571 is a selective, orally active CysLT1receptor antagonist. It blocks the binding of LTD4, but not LTC4, to human and guinea pig lung membranes with Kivalues of 0.22 nM and 2.1 nM, respectively, which is indicative of CysLT1receptor-mediated activity in these preparations. MK-571 effectively blocks LTD4activation of recombinant human and murine CysLT1receptors but is ineffective at blocking LTC4or LTD4activation of the recombinant human or murine CysLT2receptors.
(E)-3-[[[3-[2-(7-CHLORO-2-QUINOLINYL)ETHENYL]PHENYL]-[[(3-DIMETHYLAMINO)-3-OXOPROPYL]THIO]METHYL]THIO]-PROPANOIC ACID, SODIUM SALT Basic Attributes
515.09
515.09
DTXSID5048390
Yellow
Characteristics
121.10000
5.93
1.327±0.06 g/cm3(Predicted)
65-70°C
712.3±60.0 °C(Predicted)
384.6±32.9 °C
1.687
Store at -20°C
4.27±0.10(Predicted)
Store at -20°C
Drug Information
A class of drugs designed to prevent leukotriene synthesis or activity by blocking binding at the receptor level. (See all compounds classified as Leukotriene Antagonists.)|Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)
(3-(3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)((3-dimethylamino-3-oxopropyl)thio)methyl)thiopropanoic acid
(E)-3-[[[3-[2-(7-CHLORO-2-QUINOLINYL)ETHENYL]PHENYL]-[[(3-DIMETHYLAMINO)-3-OXOPROPYL]THIO]METHYL]THIO]-PROPANOIC ACID, SODIUM SALT Use and Manufacturing
A receptor antagonist for the treatment of respiratory diseases. Cysteinyl leukotriene receptor antagonist MK-571 alters bronchoalveolar lavage fluid proteome in asthma
Computed Properties
Molecular Weight:515.1
XLogP3:5.3
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:6
Rotatable Bond Count:11
Exact Mass:514.1151628
Monoisotopic Mass:514.1151628
Topological Polar Surface Area:121
Heavy Atom Count:34
Complexity:693
Undefined Atom Stereocenter Count:1
Defined Bond Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
Sulfuric acid, monodecyl ester, magnesium salt (2:1)
25446-93-9
-
Desacetyl Cephapirin SodiuM Salt
104557-24-6
-
D-Fructose, 1,6-bis(dihydrogen phosphate), sodium salt (1:4)
23784-19-2
-
Arsonic acid, methyl-, bismuth(3+) salt (3:2) Formula
85237-42-9
-
Poly(oxy-1,2-ethanediyl), α-(carboxymethyl)-ω-(decyloxy)-, sodium salt (1:1) Formula
38815-93-9
-
Benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-[[4-amino-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-, diammonium salt Formula
32866-17-4
-
Quino[2,3-b]acridine-2,9-disulfonic acid, 5,7,12,14-tetrahydro-7,14-dioxo-, aluminum salt (3:2) Structure
19795-24-5
-
Butanedioic acid, 2-sulfo-, 1-eicosyl ester, ammonium salt (1:2) Structure
94236-98-3
-
What is Phosphoric acid, monododecyl ester, ammonium salt (1:2)
65138-75-2
-
What is Phosphonic acid, [[(2-hydroxyethyl)imino]bis(methylene)]bis-, diammonium salt
84696-97-9
(E)-3-[[[3-[2-(7-CHLORO-2-QUINOLINYL)ETHENYL]PHENYL]-[[(3-DIMETHYLAMINO)-3-OXOPROPYL]THIO]METHYL]THIO]-PROPANOIC ACID, SODIUM SALT
SDSRequest for Quotation